Search

Your search keyword '"Trusheim, M."' showing total 35 results

Search Constraints

Start Over You searched for: Author "Trusheim, M." Remove constraint Author: "Trusheim, M."
35 results on '"Trusheim, M."'

Search Results

2. Invited Article: Precision nanoimplantation of nitrogen vacancy centers into diamond photonic crystal cavities and waveguides

5. From adaptive licensing to adaptive pathways: Delivering a flexible life-span approach to bring new drugs to patients

7. Corrigendum: Adaptive biomedical innovation: Evolving our global system to sustainably and safely bring new medicines to patients in need

8. 'Threshold-crossing': A Useful Way to Establish the Counterfactual in Clinical Trials?

9. 'Threshold-crossing': A Useful Way to Establish the Counterfactual in Clinical Trials?

11. “Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?

13. The next frontier: Fostering innovation by improving health data access and utilization

16. Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United States.

17. Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunity.

18. Heterogeneous integration of spin-photon interfaces with a CMOS platform.

19. Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries.

20. Payer and Developer perspectives on alternative payment models.

21. Nanoelectromechanical Control of Spin-Photon Interfaces in a Hybrid Quantum System on Chip.

22. Medicaid best price reforms to enable innovative payment models for cell and gene therapies.

23. A Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem.

24. Data for modelling US projections of product approvals, patients treated, and product revenues for durable cell and gene therapies.

25. Precision Reimbursement for Precision Medicine: Using Real-World Evidence to Evolve From Trial-and-Project to Track-and-Pay to Learn-and-Predict.

26. Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions.

27. Understanding the Rewards of Successful Drug Development - Thinking Inside the Box.

28. Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System.

29. Characterization of annual disease progression of multiple sclerosis patients: A population-based study.

30. DECISION-COMPONENTS OF NICE'S TECHNOLOGY APPRAISALS ASSESSMENT FRAMEWORK.

31. PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms.

32. Investigating investment in biopharmaceutical R&D.

33. Nanoscale Engineering of Closely-Spaced Electronic Spins in Diamond.

34. Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation.

35. Translational Medicine Guide transforms drug development processes: the recent Merck experience.

Catalog

Books, media, physical & digital resources